These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13207484)

  • 21. Studies of immunity in typhoid fever. Protection induced by killed oral antigens or by primary infection.
    Dupont HL; Hornick RB; Snyder MJ; Dawkins AT; Heiner GG; Woodward TE
    Bull World Health Organ; 1971; 44(5):667-72. PubMed ID: 5316750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of antityphoid antibodies O, H and Vi found in normal subjects during an epidemic of typhoid fever.
    OLIVO R; VENTURI R
    Ann Sanita Pubblica; 1953; 14(5):1245-53. PubMed ID: 13148974
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of typhoid vaccines: primary immunization.
    Boparai MS; Murthy RG; Varma RN
    Indian J Med Res; 1973 Jun; 61(6):802-17. PubMed ID: 4754325
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory tests of typhoid vaccines used in a controlled field study.
    EDSALL G; CARLSON MC; FORMAL SB; BENENSON AS
    Bull World Health Organ; 1959; 20(6):1017-32. PubMed ID: 13819370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of combined quadruple vaccines against diphtheria, pertussis, tetanus, and typhoid fever: reactogenicity and antigenicity.
    Cvjetanovic B; Ikić D; Lane WR; Manhalter T; Tapa S
    Bull World Health Organ; 1972; 46(1):47-52. PubMed ID: 4537334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the activity of acetone-treated antityphoid vaccine].
    GIOVANARDI A
    Boll Ist Sieroter Milan; 1957; 36(11-12):592-601. PubMed ID: 13510341
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combined vaccination against typhoid fever, paratyphoid fevers and tetanus with acetone vaccine plus tetanus anatoxin].
    GIOVANARDI A; BENZONI G; LA ROCCA V
    Minerva Med; 1954 Nov; 45(94):1327-8. PubMed ID: 13235467
    [No Abstract]   [Full Text] [Related]  

  • 31. Laboratory assays of different types of field trial typhoid vaccines and relationship to efficacy in man.
    Pittman M; Bohner HJ
    J Bacteriol; 1966 May; 91(5):1713-23. PubMed ID: 5937234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody responses to heat-killed, phenol preserved parenteral typhoid vaccine.
    Chaicumpa W; Wechsathanarak Y; Tantivanich S; Plueksawan W
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):371-6. PubMed ID: 4095599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phenylbutazone, antibodies, and proteinemia; experimental research on humans].
    COLUCCI CF; DIGILIO V
    Prog Med (Napoli); 1956 Jun; 12(11):321-31. PubMed ID: 13350404
    [No Abstract]   [Full Text] [Related]  

  • 34. Observations on the antibody response to six samples of typhoid vaccines used in India.
    GUPTA SP; GUPTA NP
    J Indian Med Assoc; 1954 May; 23(8):340-3. PubMed ID: 13163436
    [No Abstract]   [Full Text] [Related]  

  • 35. PHYSICAL AND CHEMICAL STUDIES OF TWO DRIED INACTIVATED TYPHOID VACCINES (VACCINES K AND L).
    KASI AM
    Bull World Health Organ; 1964; 30(5):647-52. PubMed ID: 14198746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines for preventing typhoid fever.
    Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stimulation of antibodies to pathogenic microorganisms in animals by immunizing them with saprophytes].
    Trutnev BD; Podlenykh TP; Klepova NI; Trepalina IuD
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jul; 46(7):98-101. PubMed ID: 4986751
    [No Abstract]   [Full Text] [Related]  

  • 38. [New type of anti-typhoid vaccine administered by the oral route and sterilized with acetone].
    BENZONI G
    Boll Ist Sieroter Milan; 1953; 32(11-12):463-9. PubMed ID: 13140467
    [No Abstract]   [Full Text] [Related]  

  • 39. [The seroprotective test in chick embryos as a method of evaluation of the oral immunizing effectiveness of inactivated TAB vaccine].
    Dimache G
    Microbiol Parazitol Epidemiol (Bucur); 1971; 16(6):519-24. PubMed ID: 5134756
    [No Abstract]   [Full Text] [Related]  

  • 40. [Considerations on the value of some laboratory tests for the evaluation of the effectiveness of the TAB vaccine].
    Chiresco N; Rímniceanu I
    Arch Roum Pathol Exp Microbiol; 1964 Mar; 23(1):261-6. PubMed ID: 4961118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.